Analysts have been eager to weigh in on the Technology sector with new ratings on Embecta Corporation (EMBC – Research Report), Fastly (FSLY – Research Report) and Gitlab (GTLB – Research Report).
Embecta Corporation (EMBC)
In a report released today, Travis Steed from Bank of America Securities maintained a Sell rating on Embecta Corporation, with a price target of $25.00. The company’s shares closed last Thursday at $24.77.
According to TipRanks.com, Steed is a 4-star analyst with an average return of
The word on The Street in general, suggests a Moderate Sell analyst consensus rating for Embecta Corporation with a $27.00 average price target.
See Insiders’ Hot Stocks on TipRanks >>
Fastly (FSLY)
In a report released today, Tal Liani from Bank of America Securities maintained a Buy rating on Fastly, with a price target of $26.50. The company’s shares closed last Thursday at $16.09.
According to TipRanks.com, Liani is a 4-star analyst with an average return of
The word on The Street in general, suggests a Hold analyst consensus rating for Fastly with a $17.79 average price target, a 12.6% upside from current levels. In a report issued on June 14, Craig-Hallum also maintained a Buy rating on the stock.
Gitlab (GTLB)
In a report released yesterday, Koji Ikeda from Bank of America Securities maintained a Buy rating on Gitlab, with a price target of $55.00. The company’s shares closed last Thursday at $49.62.
According to TipRanks.com, Ikeda is a 5-star analyst with an average return of
Gitlab has an analyst consensus of Moderate Buy, with a price target consensus of $52.31, which is an 11.9% upside from current levels. In a report issued on June 15, Barclays also reiterated a Buy rating on the stock with a $50.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on EMBC:
- UPDATE — embecta to Participate in Investor Conferences
- embecta to Participate in Investor Conferences
- Embecta Corp. Reports Second Quarter Fiscal 2023 Financial Results
- embecta and Tidepool partner to develop automated insulin delivery system for people with Type 2 diabetes
- embecta Announces Quarterly Cash Dividend
